HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaniv Lustig Selected Research

BNT162 Vaccine

3/2022Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
1/2022Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study.
1/2022Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients.
1/2022Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
1/2022Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
1/2022Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
1/2022Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours.
12/2021Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
11/2021BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study.
11/2021Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy - a single centre prospective study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaniv Lustig Research Topics

Disease

19Infections
02/2022 - 01/2016
18COVID-19
03/2022 - 01/2020
5Neoplasms (Cancer)
01/2022 - 11/2021
5Dengue (Dengue Fever)
10/2021 - 01/2019
3Breakthrough Infections
01/2022 - 10/2021
3Insulin Resistance
01/2019 - 01/2012
3West Nile Fever
01/2018 - 01/2016
2Zika Virus Infection
02/2022 - 06/2016
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 11/2021
2Pain (Aches)
11/2021 - 01/2021
2Obesity
01/2019 - 02/2014
2Viremia
01/2018 - 01/2016
1Virus Diseases (Viral Diseases)
12/2021
1Severe Acute Respiratory Syndrome
11/2021
1Hypersensitivity (Allergy)
11/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021
1Severe Dengue
01/2021
1Asymptomatic Infections
01/2020
1Glucose Intolerance
01/2019
1Inflammation (Inflammations)
01/2019
1Bites and Stings (Sting)
01/2017
1Persistent Infection
01/2016

Drug/Important Bio-Agent (IBA)

16VaccinesIBA
02/2022 - 01/2021
15BNT162 VaccineIBA
03/2022 - 01/2021
14Immunoglobulin G (IgG)IBA
01/2022 - 12/2019
10AntibodiesIBA
03/2022 - 01/2020
7Messenger RNA (mRNA)IBA
01/2022 - 10/2021
5Immunoglobulin A (IgA)IBA
01/2022 - 01/2020
4RNA (Ribonucleic Acid)IBA
11/2021 - 01/2016
4EnzymesIBA
10/2021 - 01/2019
4ImmunosorbentsIBA
10/2021 - 01/2019
4Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2014
3Immunoglobulin M (IgM)IBA
02/2022 - 01/2017
3COVID-19 VaccinesIBA
01/2022 - 01/2022
2mRNA VaccinesIBA
01/2022 - 12/2021
2Dengue VaccinesIBA
01/2021 - 12/2019
2AdiponectinIBA
02/2014 - 01/2012
1Secretory ComponentIBA
01/2022
1Neutralizing AntibodiesIBA
10/2021
1EpitopesIBA
10/2021
1P-2 (P 2)IBA
10/2021
1Saline SolutionIBA
10/2021
1AntigensIBA
08/2021
1SolutionsIBA
12/2019
1Dihydrotachysterol (AT 10)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1LipidsIBA
01/2019
1InterleukinsIBA
01/2019
1Leflunomide (Arava)FDA LinkGeneric
11/2017
1Insect RepellentsIBA
01/2017
1Amino AcidsFDA Link
01/2016
1Adiponectin ReceptorsIBA
02/2014
1RNA-Binding Proteins (RNA-Binding Protein)IBA
02/2014
1Polypyrimidine Tract-Binding ProteinIBA
02/2014
1Blood Proteins (Serum Proteins)IBA
01/2012
1Hormones (Hormone)IBA
01/2012

Therapy/Procedure

3Therapeutics
01/2022 - 11/2021
1Renal Dialysis (Hemodialysis)
02/2022
1Liver Transplantation
11/2021
1Kidney Transplantation
11/2021
1Heart Transplantation (Grafting, Heart)
11/2021
1Organ Transplantation
10/2018
1Protective Clothing
01/2017